Lipid Lowering Drugs in Atherosclerosis—the HMG-CoA Reductase Inhibitors

Informa UK Limited - Tập 11 Số 5-6 - Trang 927-941 - 1989
Geraldine Mantell1
1Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hancock E. W, 1988, Scientific American Medicine, 1

10.1001/archinte.1988.00380010040006

Lipid Research Clinic Program, 1984, JAMA, 251, 356

Study Group Strageties for the Prevention of Coronary Heart Disease, 1987, European Heart Journal, 8, 77

10.1001/jama.260.5.641

10.1073/pnas.77.7.3957

10.1073/pnas.82.18.6291

10.7326/0003-4819-107-5-609

10.1001/jama.1986.03380200067023

10.1172/JCI111044

A Multicenter Comparison of Lovastatin and Cholestyramine Therapy in Severe Primary Hypercholesterolemia, 1987, JAMA, 260, 359

Langendorfer A., 1988, Clinical Research, 36, 292A

10.7326/0003-4819-107-5-616

10.1056/NEJM198801143180204

10.1001/jama.1988.03720030022020

MEVACOR (Lovastatin, MSD) Package Insert. Merck and Co., West Point, PA 1988

Unpublished Data on File. Merck and Company, West Point, PA 1988

10.1056/NEJM198801073180112

10.1016/0002-9149(88)90004-5

Simvastatin Multicenter Group I, 1988, Amer. Coll. of Cardiology, 11, 207A

Simvastatin Multicenter Group II, 1988, American Coll. of Cardiology, 11, 207A

Hunninghake D. B., 1988, American Coll. of Cardiology, 11, 8A

10.1161/01.CIR.76.3.534